Clinical trial
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
NCT00041938 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00041938 |
|---|---|
| Title | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial |
| Official title | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial |
| Acronym | WARCEF |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Disease, Stroke, Ischemic Heart Disease, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | aspirin, Warfarin |
| Enrollment | 2,305 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2011 |
| Completion | Jul 1, 2014 |
| First posted | Jul 22, 2002 |
| Last update posted | Sep 5, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: